Olga A. Paevskaya

Olga A. Paevskaya

Auto-generated profile, based on publicly available information

Olga A. Paevskaya

Department of Infectious Diseases, Institute of Public Health named after F.F. Erisman, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2020 in Epidemiology and Infectious Diseases
Verified
Journal Article
Open access
PDF file
AFAnastasia A. Fomicheva
Anastasia A. Fomicheva
NPNikolay Pimenov
Nikolay Pimenov
SKSvetlana V. Komarova
Svetlana V. Komarova
AUAleksandr Urtikov
Aleksandr Urtikov
OPOlga A. Paevskaya
Olga A. Paevskaya
ЦНЦапкова Наталья
Цапкова Наталья
BACKGROUND: Hepatitis B is an urgent medical and social problem in Russia. AIM: To determine the epidemiological features of the hepatitis B in the Russian Arctic. MATERIALS AND METHODS: We carried out a retrospective analysis of the incidence of hepatitis B (acute and chronic forms) in 9 Russian Arctic regions, 3 subarctic regions (Khanty-Mansiysk Autonomous Okrug, Magadan Region, Kamchatka Territory) and Russian Federation in 19992019. We also studied the prevalence of chronic hepatitis B and vaccination data against hepatitis B in these territories. RESULTS: From 1999 to 2019 the incidence of acute hepatitis B in three subarctic regions decreased 166 times (from 66.5 to 0.4 per 100 thousand population), in the Arctic zone of 74.5 times (from 29.8 to 0.4 per 100 thousand population) and 73 times in Russia (from 43.8 to 0.6). The incidence of chronic hepatitis forms in the same period in the Arctic zone decreased by 8.6 times (from 140.1 to 16.3), 5.8 times in the subarctic regions (from 116.6 to 20.0) and 5.7 times in Russia (from 96.3 to 16.8). In 2018, the results of the prevalence of chronic hepatitis B in the Arctic zone (697.3) was higher than in Russia by 98% (352.1) and higher in the subarctic regions by 67% (588.6). Timely coverage of hepatitis vaccination in children aged 12 months in the Russian Federation, the Arctic zone and the subarctic regions is maintained at a high level (more than 90%) from 2004 in 2019. Coverage of children by vaccination to 17 years inclusive and adults up to 35 years on these territories also exceeded 90%. CONCLUSIONS: Vaccination against hepatitis B in the Russian Federation led to a significant decrease in the incidence of this infection in the Russian Arctic. High prevalence of infection indicates the need to continue the program of mass vaccination and the timely introduction of the first dose of vaccine newborns. To reduce the risk of cirrhosis and liver cancer, it is necessary to increase the availability of diagnosis of the disease and its possible outcomes in the Arctic regions and timely provision of antiviral treatment of all patients.

26 December 2022 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
VMValeri A. Malov
Valeri A. Malov
VPViktoriia B. Poluektova
Viktoriia B. Poluektova
ASAleksandr P. Shakotko
Aleksandr P. Shakotko
OTOleg A. Tishkevich
Oleg A. Tishkevich
VMViktor V. Maleyev
Viktor V. Maleyev
NMNatalya V. Maloletneva
Natalya V. Maloletneva
The article describes a clinical case of an unfavorable course of pasteurellosis in a patient with liver cirrhosis. Possible variants of the clinical course, clinical and epidemiological data, on the basis of which pasteurellosis can be suspected, modern recommendations for antibiotic therapy are considered.

23 December 2025 in Epidemiology and Infectious Diseases
Verified
Journal Article
Closed access
PDF file
OBOlga F. Belaia
Olga F. Belaia
DGDenis S. Gutkin
Denis S. Gutkin
MVMaria S. Vakhrameeva
Maria S. Vakhrameeva
OPOlga A. Paevskaya
Olga A. Paevskaya
ASAnna N. Sundukova
Anna N. Sundukova
ВСВахрамеева Мария Сергеевна
Вахрамеева Мария Сергеевна
BACKGROUND: Identification of Helicobacter pylori pathogenicity factors is crucial for improving diagnosis and understanding the pathogenesis of associated diseases. AIM: The study aimed to establish the detection rates of markers associated with major H. pylori pathogenic factors in patients with chronic gastritis and peptic ulcer. METHODS: The study included 67 patients with chronic gastritis and 57 patients with peptic ulcer. All participants underwent a fibroesophagogastroduodenoscopy with a rapid urease test (AMA LLC, Russia), followed by a histological examination for H. pylori. The following were also tested: stool filtrates for H. pylori antigen using an immunochromatographic assay (H. pylori test, Novamed Ltd., Israel); serum for anti-CagA antibodies via enzyme-linked immunosorbent assay (Anti-Helicobacter pylori CagA ELISA, ECOlab JSC, Russia); and fecal and salivary samples for O antigen (LPS), VacA, and CagA antigens using a coagglutination test (Gamaleya National Research Center for Epidemiology and Microbiology, Russia). RESULTS: Positive rapid urease test results were obtained in 61.9% of patients. Serum CagA antibodies were detected in 51% of patients, and H. pylori antigen was detected in the feces of 27.9% of patients (p ≥ 0.05). The coagglutination test demonstrated the highest diagnostic performance: O antigen, VacA, and CagA antigens were detected in the fecal and/or salivary samples of 83.1% of patients at a diagnostic titer threshold of ≥1:8, which was significantly higher than that achieved by other tests. The rate of CagA antibody detection in serum was twice as high with a positive rapid urease test result. Esophagogastroduodenoscopy and rapid urease testing revealed H. pylori in 40.3% (27) of patients with chronic gastritis and in 56.1% (31) of patients with peptic ulcers. The coagglutination test detected VacA and/or CagA antigens in 90.6% of stool filtrate samples and 88.5% of salivary samples. Both antigens simultaneously were detected in 67.5% and 65.1% of the fecal and salivary samples, respectively. The rate of simultaneous detection of VacA and CagA antigens in feces was significantly higher in patients with peptic ulcers and positive rapid urease test results compared with other subgroups. There was no significant difference in the rate of simultaneous detection of these antigens in saliva across patient subgroups. CONCLUSION: The primary advantage of the coagglutination test is the non-invasive, simultaneous detection of three key, synergistic H. pylori pathogenicicty factors in feces and/or saliva: O antigen (a marker of replication), VacA antigen (vacuolating cytotoxin), and CagA antigen (a pathogenicity island marker and Class I bacterial co-oncogene) The study confirmed that saliva can be used to detect H. pylori in children and older patients, when invasive testing is not an option.

17 May 2026 in Clinical and Translational Oncology
Verified
Journal Article
Closed access
ENElena A. Nemilostiva
Elena A. Nemilostiva
OPOlga A. Paevskaya
Olga A. Paevskaya
SBShuxrat Boymuradov
Shuxrat Boymuradov
BSBaqodir Safoyev
Baqodir Safoyev
MSMirmukhsin Satov
Mirmukhsin Satov

14 December 2025 in Epidemiology and Infectious Diseases
Verified
Journal Article
Closed access
PDF file
LKLarisa N. Kokoreva
Larisa N. Kokoreva
ODOlga V. Darvina
Olga V. Darvina
MSMaria B. Sviridova
Maria B. Sviridova
SASona R. Ayvazyan
Sona R. Ayvazyan
KUKarina T. Umbetova
Karina T. Umbetova
NKNatalia V. Kolaeva
Natalia V. Kolaeva
Echinococcosis is a human parasitic disease widespread in many countries because of population migration, occupational risk factors, and increased tourism. The clinical symptoms are non-specific and manifest late. Echinococcosis is often discovered incidentally in clinical practice. Diagnostic errors can result from low awareness of healthcare professionals regarding echinococcosis in regions with low incidence rates. This article describes a case report of imported echinococcosis in a patient with chickenpox (varicella) diagnosed at Infectious Diseases Clinical Hospital No. 2 of the Moscow Healthcare Department in April 2021. The patient came from Kyrgyzstan, where he worked as a sheep farmer. Inpatient ultrasound and computed tomography of the abdomen and retroperitoneum revealed multiple cystic liver lesions of parasitic origin. An enzyme-linked immunosorbent assay revealed the IgG antibodies to Echinococcus antigens. This clinical case highlights the ongoing relevance of echinococcosis in Russia and underscores the need for a comprehensive analysis of clinical, epidemiological, laboratory, and imaging data. These findings also suggest the importance of raising awareness among healthcare professionals about this infection, especially when treating migrants from endemic regions with cystic liver lesions and patients in high-risk groups.

17 December 2025 in Acta Biomedica Scientifica
Verified
Journal Article
Closed access
ZZZ. R.-L. Zaranaina
Z. R.-L. Zaranaina
SSSvetlana Suslina
Svetlana Suslina
YKY. K. Kozlova
Y. K. Kozlova
AEA. M.-A. Ebzeyeva
A. M.-A. Ebzeyeva
OPO. A. Paevskaya
O. A. Paevskaya
ELENA MARUSICHELENA MARUSICH
ELENA MARUSICH
Rationale . Piper betle of the family of Piperaceae, (P. betle) is a liana growing in the tropics of the Indonesian-Asian region, has long been actively used in folk medicine as a source of remedies for a variety of health problems. At the same time, the methods and purposes of using P. betle in folk medicine vary from region to region, and the effectiveness of its impact on human remains fully underestimated. The aim of the study . To systematize and analyze modern literature data on the pharmacological potential of the medicinal plant Piper betle, growing in the countries of Madagascar, India, Bali and China of the Indonesian-Asian region. Materials and methods . The search and analysis of data were carried out in international and regional databases (PubMed, Scopus, Web of Science, Science Direct, and Google Scholar) for the period from 1996 to 2025. Results . The analysis of scientific literature data showed that the target fragment of metabolome (TFM) of Peper betle is characterized by a complex composition of biologically active compounds (BAS), which varies significantly from region to region. BAS of the TFM of this plant are responsible for various types of pharmacological activity, which justifies its use in traditional medicine and growing interest to the medical scientific community. It was found that within the range of P. betle growth, the chemical composition of TFM varies in terms of the content of alkaloids, terpenes, phenolic compounds, including flavonoids and volatile components. Conclusion . P. betle is a promising object for further research in the field of phytopharmacology and reproductive medicine. Obviously, in-depth preclinical and clinical studies are needed to confirm the identified effects based on literature sources. At the same time, the collected literature data can contribute to future research in the field of pharmacology in order to create new promising drugs.